filmov
tv
CNET News - First FDA-approved bionic eye ready for commercial launch in US

Показать описание
After more than 20 years in the making, the world's first FDA-approved bionic eye will soon be launching commercially in the United States. The device could help the tens of thousands of people who suffer from a rare, degenerative eye disease. CNET's Sumi Das explains how the Argus II device works to bring light into the darkness.
CNET News - First FDA-approved bionic eye ready for commercial launch in US
FDA Approves First Bionic Eye
The Apple Watch ECG found something unexpected about my heart
Samsung gets the green light for augmented-reality contacts (CNET News)
Tomorrow Daily 127: An FDA-approved exoskeleton, Spider-Man comes back to Marvel and more
CNET Update - FAA's proposed drone regulations have Amazon grounded
CNET Update - Black Friday begins early online
Apple's new sleep apnea feature approved by FDA
CNET Update Instagram gets intimate with private photos
CNET Update - Twitter IPO reveals interesting tidbits
CNET News Finding your lost dog is now a snap shot
InWith says it's developed world's first soft electronic contact lens
CNET's live coverage of Apple's 2018 iPhone big reveal
Nike's HyperAdapt power-lacing sneakers are pretty McFly (CNET Update)
CNET News - 'Star Trek' tricorder becomes reality
I Tested a Mind-Controlled Prosthetic Arm and Was Blown Away
Apple Watch Series 4 First Look
CBS CNET:: VSee is the new telemedicine technology that maintains patient privacy
The F.D.A. Approves a Bionic Eye: Argus II Device Helps the Blind | The New York Times
iPhone 16: Preorder or Wait? Why Apple Watch 10, AirPods Stole the Show
How to eat Roti #SSB #SSB Preparation #Defence #Army #Best Defence Academy #OLQ
CNET Next Big Thing: Health and technology
The world's smallest dynamic display for your eye
Ohio State First to Implant Newly-Approved Wireless Heart Failure Monitor
Комментарии